Newsroom
March 13, 2015
Patients with life-threating fungal infections have new hope for survival and less-severe side effects with the U.S. Food and Drug Administration’s approval of a new drug, isavuconazonium sulfate, also called CRESEMBA®.
January 12, 2015
Jan E. Patterson, M.D., M.S., of the School of Medicine at The University of Texas Health Science Center at San Antonio, has been appointed to serve on the Healthcare Infection Control Practices Advisory Committee of the U.S. Centers for Disease Control and Prevention.
October 25, 2012
Thomas Patterson, M.D., professor of medicine and chief of infectious diseases in the School of Medicine at The University of Texas Health Science Center San Antonio, is available for interviews about the fungal meningitis outbreak.
July 2, 2012
Jan Evans Patterson, M.D., M.S., infectious diseases physician with UT Medicine San Antonio, today was appointed to the Subspecialty Board on Infectious Disease of the American Board of Internal Medicine.
March 9, 2009
New research may have uncovered a strategy for strengthening the only vaccine available today for protection against tuberculosis.
January 7, 2008
Thomas F. Patterson, M.D., FACP, professor of medicine at The University of Texas Health Science Center at San Antonio and director of the San Antonio Center for Medical Mycology, has been elected to a two-year term as a member of the Subspecialty Board on Infectious Disease of the American Board of Internal Medicine.